Abstract
This case discusses the pharmacokinetic interaction between cyclobenzaprine and smoked tobacco resulting in cyclobenzaprine toxicity due to reversal of enzyme induction. Cyclobenzaprine is a cytochrome P450 1A2 substrate. Smoked tobacco is a 1A2 inducer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang RW, Liu L, Cheng H. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine. Drug Metab Dispos. 1996;24(7):786–91.
Schaffer SD, Yoon S, Zadezensky I. A review of smoking cessation: potentially risky effects on prescribed medications. J Clin Nurs. 2009;18(11):1533–40.
Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76:178–84.
Chabria SB. Rhabdomyolysis: a manifestation of cyclobenzaprine toxicity. J Occup Med Toxicol. 2006;1:16.
Spiller HA, Winter ML, Mann KV, et al. Five-year multicenter retrospective review of cyclobenzaprine toxicity. J Emerg Med. 1995;13(6):781–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ramchandani, A., Gonzalez-Sotomayor, J.A. (2015). When the Smoke Clears, Relaxation Disappears. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_72
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7495-1_72
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7494-4
Online ISBN: 978-1-4614-7495-1
eBook Packages: MedicineMedicine (R0)